Esther Pohl

1.6k total citations
8 papers, 207 citations indexed

About

Esther Pohl is a scholar working on Genetics, Molecular Biology and Cell Biology. According to data from OpenAlex, Esther Pohl has authored 8 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Molecular Biology and 2 papers in Cell Biology. Recurrent topics in Esther Pohl's work include BRCA gene mutations in cancer (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Moyamoya disease diagnosis and treatment (1 paper). Esther Pohl is often cited by papers focused on BRCA gene mutations in cancer (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Moyamoya disease diagnosis and treatment (1 paper). Esther Pohl collaborates with scholars based in Germany, Türkiye and Switzerland. Esther Pohl's co-authors include Peter Nürnberg, Gudrun Nürnberg, Bernd Wollnik, Burak Durmaz, Ferda Özkınay, Katharina Keupp, Filippo Beleggia, Gökhan Yigit, Sema Kalkan Uçar and Mahmut Çöker and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Human Genetics and Annals of Oncology.

In The Last Decade

Esther Pohl

8 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther Pohl Germany 5 109 73 67 36 18 8 207
Lucie Vizor United Kingdom 8 190 1.7× 53 0.7× 25 0.4× 17 0.5× 17 0.9× 15 336
Adi D. Sabag Israel 9 186 1.7× 21 0.3× 52 0.8× 20 0.6× 11 0.6× 19 321
Muhammad Salman Chishti Pakistan 11 268 2.5× 120 1.6× 159 2.4× 19 0.5× 36 2.0× 14 385
Ace E. Lewis United States 6 230 2.1× 114 1.6× 34 0.5× 11 0.3× 6 0.3× 6 306
MaryPat Jones United States 9 153 1.4× 144 2.0× 24 0.4× 31 0.9× 11 0.6× 9 326
Julie Batut France 11 274 2.5× 35 0.5× 44 0.7× 20 0.6× 6 0.3× 22 338
Srirangan Sampath United States 8 165 1.5× 102 1.4× 35 0.5× 27 0.8× 6 0.3× 12 246
Clemer Abad United States 10 238 2.2× 178 2.4× 15 0.2× 57 1.6× 16 0.9× 20 360
Britta M. Grebbin Germany 8 197 1.8× 45 0.6× 22 0.3× 22 0.6× 25 1.4× 8 283
Sameera Sogaty Saudi Arabia 8 179 1.6× 105 1.4× 52 0.8× 33 0.9× 14 0.8× 8 255

Countries citing papers authored by Esther Pohl

Since Specialization
Citations

This map shows the geographic impact of Esther Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Pohl more than expected).

Fields of papers citing papers by Esther Pohl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Pohl. The network helps show where Esther Pohl may publish in the future.

Co-authorship network of co-authors of Esther Pohl

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Pohl. A scholar is included among the top collaborators of Esther Pohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Pohl. Esther Pohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pohl, Esther, Andreas Schneeweiß, Jan Hauke, et al.. (2018). Germline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study. Annals of Oncology. 29. viii77–viii77. 2 indexed citations
2.
Pohl, Esther, Jan Hauke, Judit Horváth, et al.. (2017). NGS-based multi-gene panel analysis in BRCA1/2-negative breast and ovarian cancer families.. Journal of Clinical Oncology. 35(15_suppl). 1526–1526. 1 indexed citations
3.
Yigit, Gökhan, Karen E. Brown, Hülya Kayserili, et al.. (2015). Mutations in CDK 5 RAP 2 cause Seckel syndrome. Molecular Genetics & Genomic Medicine. 3(5). 467–480. 44 indexed citations
4.
Schreml, Julia, Burak Durmaz, Özgür Çoğulu, et al.. (2013). The missing “link”: an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation. Human Genetics. 133(1). 29–39. 55 indexed citations
5.
Pohl, Esther, Ayça Aykut, Filippo Beleggia, et al.. (2013). A hypofunctional PAX1 mutation causes autosomal recessively inherited otofaciocervical syndrome. Human Genetics. 132(11). 1311–1320. 42 indexed citations
6.
Li, Yun, Esther Pohl, Redouane Boulouiz, et al.. (2010). Mutations in TPRN Cause a Progressive Form of Autosomal-Recessive Nonsyndromic Hearing Loss. The American Journal of Human Genetics. 86(3). 479–484. 43 indexed citations
7.
Molčányi, Marek, Peter Rieß, Esther Pohl, et al.. (2007). Embryonic stem cells produce neurotrophins in response to cerebral tissue extract: Cell line‐dependent differences. Journal of Neuroscience Research. 85(5). 1057–1064. 18 indexed citations
8.
Sperlich, Diether, et al.. (1967). [Test of the mutagenic effect of radon 222 in the Drosophila melanogaster].. PubMed. 132(1). 105–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026